Spirepoint Private Client’s Ingredion INGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,429
Closed -$268K 334
2025
Q4
$268K Sell
2,429
-34,534
-93% -$3.89M 0.03% 258
2025
Q3
$4.51M Sell
36,963
-40
-0.1% -$5.16K 0.47% 52
2025
Q2
$5.02M Sell
37,003
-34
-0.1% -$4.59K 0.57% 53
2025
Q1
$5.01M Buy
37,037
+1,489
+4% +$197K 0.65% 45
2024
Q4
$4.89M Buy
35,548
+565
+2% +$79.5K 0.61% 46
2024
Q3
$4.81M Sell
34,983
-384
-1% -$48.8K 0.64% 45
2024
Q2
$4.06M Buy
35,367
+107
+0.3% +$12.4K 0.58% 44
2024
Q1
$4.12M Buy
+35,260
New +$3.97M 0.63% 42

Other funds holding INGR

Spirepoint Private Client's INGR Position: Q1 2026 in Review

Spirepoint Private Client sold out of Ingredion (INGR) in Q1 2026, closing a stake of 2,429 shares — an estimated $268K sold.

Spirepoint Private Client first reported a position in INGR in Q1 2024 and held it in 8 quarters. The position peaked at $5.02M in Q2 2025. 665 funds tracked by Wall St. Rank hold INGR as of Q1 2026.

  • Spirepoint Private Client reported no remaining Ingredion position as of Q1 2026 after selling out during the quarter.
  • Spirepoint Private Client sold 2,429 Ingredion shares in Q1 2026, an estimated $268K.
  • Spirepoint Private Client first reported a position in Ingredion in Q1 2024 and held it in 8 quarters.
  • Spirepoint Private Client's Ingredion position peaked at $5.02M in Q2 2025.
  • 665 funds tracked by Wall St. Rank held Ingredion as of Q1 2026.

Based on Spirepoint Private Client's 13F filing for Q1 2026, filed 22 Apr 2026.